Aude Ouensanga joined Alira Health France as Analyst in 2012 and since then she has handled various strategy and business development projects in the pharma/biotech and medical device spaces. In the past years, she developed knowledge in several segments of Healthcare including Pharmaceuticals (early and late stage), Diagnostics, Healthcare Acquired Infections (HAI) and Fluid Management while advising on M&A, Licensing, Fundraising, Market Entry Strategy and Commercial Due Diligence. Prior to joining Alira, Aude had been a M&A Analyst at BNP Paribas Corporate & Investment Banking for the chemicals sector and Business Analyst at Novartis Pharma for the mature products portfolio and one of the company’s blockbusters. Aude joined Alira Health Boston office in 2015. Aude holds a degree from French Grande Ecole EM Lyon Business School where she specialized in Finance and Strategy. Aude holds FINRA Series 79 and 63 certifications.